YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorLiu Hongfang

About this trial

In order to reduce the clinical demand for kidney dialysis rate of Diabetic Kidney Disease(DKD) patients, a bidirectional cohort study of 4472 patients with DKD (Qi deficiency and collateral stasis syndrome) was carried out based on a preliminary DKD cohort of 13,000 patients. The exposure factor was supplementing and reducing the kidney turbidity-Huoxue Tongluo method represented by the addition and subversion of Shenzhuo prescription, and the incidence of end-stage renal disease was the main therapeutic index. Follow-up was conducted for 2 years

Eligibility criteria

Qualifiers

1 in line with Western medicine diagnostic criteria for type 2 diabetic kidney disease ;

2 18-80 years old, regardless of gender ;

3 eGFR > 15ml / ( min · 1.73m2 ) ; the eGFR was calculated according to the chronic kidney disease epidemiology collaboration equation ( CKD-EPI ).

4 In line with the diagnostic criteria of qi deficiency and collateral stasis syndrome in traditional Chinese medicine ;

Disqualifiers

1 combined with other clear renal diseases, such as polycystic kidney disease, glomerulonephritis, renal tumor, etc. ;

2 patients with a history of recurrent genitourinary tract infection ;

3 combined with cardiovascular and cerebrovascular, digestive, respiratory, urinary, immune system serious diseases or mental diseases ;

4 currently in pregnancy, lactation, or pregnancy plan women ;

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

4,472 Participants
are grouped into 2 trial groups

Sponsors and collaborators

Liu Hongfang

Lead sponsor

Dongzhimen Hospital, Beijing

Sponsor institution

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Collaborator

First Affiliated Hospital, Sun Yat-Sen University

Collaborator

Tianjin Medical University

Collaborator

Changchun University of Chinese Medicine

Collaborator

EFONG PHARMRCEUTICRL

Collaborator

Xinxiang Central Hospital of Henan province

Collaborator

Xiamen Hospital of Traditional Chinese Medicine

Collaborator

Affiliated Hospital of Liaoning University of Traditional Chinese Medicine

Collaborator

Beijing Tiantan Hospital

Collaborator

Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine

Collaborator

Hubei Zhongshan Hospital Affiliated to Wuhan University

Collaborator